A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

September 30, 2006

Conditions
Carcinoma, Small Cell
Interventions
DRUG

Pemetrexed

Trial Locations (3)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Aurora

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Chapel Hill

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191750 - A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | Biotech Hunter | Biotech Hunter